GAMMA Investing LLC Has $273,000 Holdings in Enhabit, Inc. (NYSE:EHAB)

GAMMA Investing LLC lifted its stake in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 3,373.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,055 shares of the company's stock after acquiring an additional 30,161 shares during the period. GAMMA Investing LLC owned approximately 0.06% of Enhabit worth $273,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. PharVision Advisers LLC acquired a new stake in Enhabit in the 4th quarter valued at approximately $317,000. Squarepoint Ops LLC bought a new position in shares of Enhabit during the 4th quarter worth approximately $185,000. Two Sigma Advisers LP grew its stake in shares of Enhabit by 40.1% during the 4th quarter. Two Sigma Advisers LP now owns 27,600 shares of the company's stock worth $216,000 after acquiring an additional 7,900 shares in the last quarter. State of Wyoming raised its holdings in shares of Enhabit by 95.7% in the fourth quarter. State of Wyoming now owns 71,307 shares of the company's stock valued at $557,000 after purchasing an additional 34,861 shares during the last quarter. Finally, Systematic Financial Management LP lifted its position in shares of Enhabit by 8.6% in the fourth quarter. Systematic Financial Management LP now owns 1,996,113 shares of the company's stock worth $15,590,000 after purchasing an additional 157,914 shares in the last quarter.

Analysts Set New Price Targets

Separately, Jefferies Financial Group reiterated a "buy" rating on shares of Enhabit in a research note on Thursday, March 6th.

Enhabit Stock Down 1.2%

EHAB traded down $0.11 on Wednesday, hitting $9.40. 358,472 shares of the company were exchanged, compared to its average volume of 455,638. The stock's fifty day moving average is $9.44 and its 200-day moving average is $8.68. Enhabit, Inc. has a 12 month low of $6.85 and a 12 month high of $10.91. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.49 and a current ratio of 1.49. The company has a market cap of $476.02 million, a PE ratio of -3.39 and a beta of 1.80.

Enhabit (NYSE:EHAB - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.07 by $0.03. Enhabit had a positive return on equity of 2.02% and a negative net margin of 13.43%. The company had revenue of $259.90 million for the quarter, compared to analysts' expectations of $266.11 million. Equities research analysts predict that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.